Cencora, Inc. (COR) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Distribution Branche. Der Hauptsitz des Unternehmens ist in Conshohocken, PA, United States. Der aktuelle CEO ist Robert Mauch.
COR hat IPO-Datum 1995-04-04, 47,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $62.23B.
Cencora, Inc. is a leading pharmaceutical distributor that sources and distributes a comprehensive range of healthcare products across the United States and internationally. The company's U.S. Healthcare Solutions segment supplies generic and specialty pharmaceuticals, vaccines, over-the-counter products, and medical equipment to hospitals, pharmacies, clinics, and other healthcare providers, while also offering pharmacy management services, software solutions, and specialized support for biotechnology companies. Its International Healthcare Solutions segment provides pharmaceutical wholesale distribution and logistics services to healthcare facilities globally. Founded in 1871 and headquartered in Conshohocken, Pennsylvania, Cencora serves diverse markets including human healthcare, animal health, and biopharmaceutical commercialization.
